BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14768703)

  • 1. A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection.
    Obata H; Hayashi N; Motoike Y; Hisamitsu T; Okuda H; Kobayashi S; Nishioka K
    Int J Cancer; 1980 Jun; 25(6):741-7. PubMed ID: 14768703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis.
    Coppola N; Onorato L; Sagnelli C; Sagnelli E; Angelillo IF
    Medicine (Baltimore); 2016 Jul; 95(30):e4311. PubMed ID: 27472708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
    Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
    Ikeda K; Marusawa H; Osaki Y; Nakamura T; Kitajima N; Yamashita Y; Kudo M; Sato T; Chiba T
    Ann Intern Med; 2007 May; 146(9):649-56. PubMed ID: 17470833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of hepatitis C virus with liver cirrhosis and hepatocellular carcinoma compared with hepatitis B virus in Egyptian patients.
    Darwish MA; Amer AF; El-Moeity AA; Darwish NM
    J Egypt Public Health Assoc; 1997; 72(5-6):569-89. PubMed ID: 17214153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus infection in liver cirrhosis and hepatocellular carcinoma in Jakarta Indonesia.
    Sulaiman HA
    Gastroenterol Jpn; 1989 Aug; 24(4):434-41. PubMed ID: 2550307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.
    Coppola N; Onorato L; Iodice V; Starace M; Minichini C; Farella N; Liorre G; Filippini P; Sagnelli E; de Stefano G
    Oncotarget; 2016 Sep; 7(38):62706-62714. PubMed ID: 27486882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.
    Park YM; Lee SG
    World J Gastroenterol; 2016 Nov; 22(44):9836-9843. PubMed ID: 27956808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus.
    Lee HL; Bae SH; Lee J; Sung PS; Lee SW; Jang JW; Lee J; Choi JY; Han NI; Yoon SK
    Cancer Control; 2021; 28():10732748211039758. PubMed ID: 34569320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.